期刊文献+

不同年龄、性别的冠心病患者住院费用分析 被引量:5

Effects of age and gender on hospitalization costs in patients with coronary artery disease
下载PDF
导出
摘要 目的分析不同年龄、性别及其他临床情况对于冠状动脉造影患者住院费用的影响。方法研究对象为2001年1月1日至2006年12月3113北京协和医院心内科住院患者,年龄在40-79岁之间,有完整的各项住院费用记录。住院费用包括药费、检查费、治疗费、床位费、材料费、其他费用以及总费用。所有患者均进行了冠状动脉造影(CAG),部分患者进行了冠脉介入处理。结果40-59岁男性患者1130例,60-79岁男性患者1167例,40-59岁女性患者420例,60-79岁女性患者903例,各组患高血压病、心肌梗死、脑中风、糖尿病等疾病的比例差异有统计学意义(P〈0.01)。不同年龄性别组住院总费用在23237.11~47282.72元,从多到少排序分别为60-79岁男性患者、60~79岁女性患者、40~59岁男性患者和40~59岁女性患者。冠脉无明显狭窄患者以及CAG明显狭窄但未进行介入处理的患者,各组间总费用虽然有一定的差异,但无统计学意义。CAG明显狭窄并进行介入处理的患者,总费用在各组问差异有统计学意义,年龄大组的各项费用大于年轻组的费用。同一年龄性别组的不同冠脉处理情况的住院费用比较,有冠脉狭窄未介入处理亚组住院总费用为14771.99-21967.94元,冠状动脉无明显狭窄亚组住院总费用为8787.55—10757.86元,前者是后者的1.68-2.28倍,材料费是2.16-3.99倍,治疗费是1.12~2.51倍,检查费是1.31-1.56倍,药费是1.89~2.14倍,差异均有统计学意义(P〈0.01);冠状动脉介入处理亚组住院总费用(57356.76-67420.77元)是冠状动脉无明显狭窄亚组的6.13-7.01倍,材料费是13.99-17.251倍,治疗费是3.53-4.50倍,检查费是1.40~1.87倍,药费是2.52~2.90倍,差异均有统计学意义(P〈0.01)。住院总费用与是否介入、性别、年龄、高血压、心肌梗死、中风病史、外周血管病史、糖尿病和肾功不全等均有一定相关性,住院总费用与以上各项参数进行多元逐步回归分析,住院费用与是否冠脉介入、心肌梗死史、年龄、高血压、糖尿病、是否有外周血管病和肾功能不全7项参数有独立相关性。结论年龄越大,住院费用越高,性别不是住院总费用的独立影响因素;影响住院总费用的其他独立因素包括是否进行冠脉介入,是否有心肌梗死史、高血压、糖尿病、外周血管病和肾功能不全。 Objective To investigate the effects of age, gender and other clinical situation on in-hospital medical expenses in patients who underwent coronary angiography and coronary artery intervention(PCI). Methods Patients who were aged 40 to 79 years and admitted to the Cardiology ward of Peking Union Medical College Hospital during Jan 1,2001 to Dec 31, 2006 and had complete hospitalization cost records were studied. Hospitalization costs include medication, examination, treatment, bed, material and others. All patients had coronary angiography and some of them had coronary artery intervention. Results A total of 3620 patients were divided into four groups based on age and gender, (1)male and age 40-59(n=1130), (2)male and age 60-79(n=1167), (3)female and age 40-59(n=420), (4)female and age 60-79(n=903 ). There were differences in prevalence of hypertension, old myocardial infarction, stroke, diabetes (all P〈0.01 ). The total hospitalization costs were higher in older patients in both sexes, with older male patient having highest costs and younger female patient lowest costs. In non- PCI patients, the cost differences were not statistical significant between normal and abnormal coronary artery groups. In PCI patients, the total costs were greater in the older group than that in the younger group. In the same age-sex group, the total cost was 1.68-2.28 times, material cost was 2.16-3.99 times, treatment cost was 1.12- 2.51 times, examination cost was 1.31-1.56 times, medication cost was 1.89-2.14 times in the patients with stenosis coronary artery compared to the no stenosis coronary artery, and the differences were significant(P〈0.01 ). The total cost was 6.13-7.01 times, material cost was 13.99-17,25 times, treatment cost was 3.53-4.50 times, examination cost was 1.40-1.87 times, medication cost was 2.52-2.90 times in the PCI patients comparing to the non PC1 patients with stenosis coronary artery, and the differences were significant(P〈0.01 ). PCI, older age, history of myocardial infarction, hypertension, diabetes, peripheral vascular disease and renal dysfunction were the independent predictors of hospitalization costs. Conclusion Hospitalization costs is higher in older patients. PCI, myocardial infarction, diabetes, hypertension, peripheral vascular disease and renal dysfunction further increase patients' economic burden.
出处 《中国心血管病研究》 CAS 2009年第11期827-832,共6页 Chinese Journal of Cardiovascular Research
关键词 年龄 性别 冠状动脉疾病 冠脉介入术 住院费用 Age Gender Coronary disease Pereutaneous coronary intervention Hospitalization costs
  • 相关文献

参考文献11

二级参考文献28

  • 1汤胜蓝,陈家应,龚幼龙,Gerald Bloom,缪宝迎.城市居民疾病直接经济负担分析[J].中国卫生资源,2001,4(5):202-204. 被引量:10
  • 2王伟,龚幼龙,姜庆五,陈家应,龚雪飞,张兵.城市居民的慢病现况及其经济负担研究[J].中国卫生资源,2001,4(5):205-207. 被引量:8
  • 3马丽,刘苏健,邓勇志,马捷,孙宗全,胡志伟.靶向Pik3cb RNA干扰对大鼠血管平滑肌细胞增殖的影响[J].中华普通外科杂志,2007,22(5):378-381. 被引量:3
  • 4邓勇志,刘苏健,马丽,孙宗全,陈家军,苏刚,刘超,王国华,柯俊.局部RNA干扰下调磷脂酰肌醇3激酶-Akt信号通路抑制大鼠颈静脉颈动脉间置模型静脉移植血管新生内膜增生[J].中华医学杂志,2007,87(24):1713-1716. 被引量:3
  • 5[1]Trivedi RA,Mallawarachi C,U-King-Im JM,et al.Identifying inflamed carodd plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages.Arterioscler Thromb Vasc Biol,2006,26:1601-1606.
  • 6[2]Tang T,Howarth SP,Miller SR,et al.Assessment of inflammatory burden contralateral to the symptomatic carotid stenesis using high-resolution uhrasmall.superparamagnetic iron oxide-enhanced using high-resolution ultrasmall,superparamagnetic iron oxide-enhanced MRI.Stroke,2006,37:2266-2270.
  • 7[3]Okane K,lbaraki M,Toyeshima H,et al.18F-FDG accumulation in atheresclerosis:use of CT and MR co-registration of thoracic and carotid arteries.Eur J Nuel Med Mol Imaging,2006,33:589-594.
  • 8[4]Tahara N,Kai H,Ishibashi M,et al.Simvastatin attenuates plaque inflammation:evaluation by fluorodeoxyglucose positron emission tomography.J Am Coil Cardiol,2006,48:1825-1831.
  • 9[5]Davies JR,Rudd JH,Weissberg PL,et al.Radionuclide imaging for the detection 0f inflammation in vulnerable plaques.J Am Coil Cardiol,2006,47:C57-C68.
  • 10[6]Clinical Trials.gov.Available at:http://www.clinicaltrials.gov.Accessed March 15,2007.

共引文献203

同被引文献51

引证文献5

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部